$CFFI
C&F Financial Corp

2023 Q2 Form 10-Q Financial Statement

#000091334123000027 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $32.11M $32.40M
YoY Change 13.48% 19.1%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $975.0K $988.0K
YoY Change -10.3% -12.95%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $6.393M $4.347M
YoY Change 263.03% 147.69%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $7.917M $7.950M
YoY Change -8.63% 8.58%
Income Tax $1.533M $1.453M
% Of Pretax Income 19.36% 18.28%
Net Earnings $6.306M $6.441M
YoY Change -6.47% 14.43%
Net Earnings / Revenue 19.64% 19.88%
Basic Earnings Per Share $1.84 $1.86
Diluted Earnings Per Share $1.84 $1.86
COMMON SHARES
Basic Shares Outstanding 3.435M 3.467M
Diluted Shares Outstanding 3.425M 3.465M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $58.91M $84.22M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $42.77M $43.51M
YoY Change -2.37% -3.26%
Goodwill $25.19M $25.19M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $21.93M $21.02M
YoY Change 11.18% 22.24%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.419B $2.440B
YoY Change 3.65% 6.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.405M $1.612M
YoY Change 264.39% 271.43%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $124.2M $145.6M
YoY Change 236.2% 348.85%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $126.6M $147.2M
YoY Change 19079.55% 33814.98%
LONG-TERM LIABILITIES
Long-Term Debt $51.40M $55.44M
YoY Change -7.57% -0.4%
Other Long-Term Liabilities $41.47M $38.72M
YoY Change 6.78% -8.62%
Total Long-Term Liabilities $92.87M $94.16M
YoY Change -1.67% -3.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $126.6M $147.2M
Total Long-Term Liabilities $92.87M $94.16M
Total Liabilities $2.217B $2.237B
YoY Change 3.69% 6.5%
SHAREHOLDERS EQUITY
Retained Earnings $225.9M $221.1M
YoY Change 11.07% 11.64%
Common Stock $3.269M $3.309M
YoY Change -3.43% -2.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $201.9M $202.6M
YoY Change
Total Liabilities & Shareholders Equity $2.419B $2.440B
YoY Change 3.65% 6.02%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $6.306M $6.441M
YoY Change -6.47% 14.43%
Depreciation, Depletion And Amortization $975.0K $988.0K
YoY Change -10.3% -12.95%
Cash From Operating Activities -$972.0K $165.0K
YoY Change -111.86% -99.6%
INVESTING ACTIVITIES
Capital Expenditures $95.00K $515.0K
YoY Change -149.22% -57.19%
Acquisitions
YoY Change
Other Investing Activities $3.540M $4.714M
YoY Change -102.01% 2434.41%
Cash From Investing Activities $3.445M -$39.49M
YoY Change -101.95% -56.35%
FINANCING ACTIVITIES
Cash Dividend Paid $1.521M
YoY Change 7.11%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -27.79M 96.89M
YoY Change -172.76% 91.93%
NET CHANGE
Cash From Operating Activities -972.0K 165.0K
Cash From Investing Activities 3.445M -39.49M
Cash From Financing Activities -27.79M 96.89M
Net Change In Cash -25.32M 57.56M
YoY Change -80.53% 4724.73%
FREE CASH FLOW
Cash From Operating Activities -$972.0K $165.0K
Capital Expenditures $95.00K $515.0K
Free Cash Flow -$1.067M -$350.0K
YoY Change -112.71% -100.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
40518000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1632361000
CY2023Q1 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
1209000
CY2022Q1 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
387000
CY2023Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
1820000
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000913341
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
C & F FINANCIAL CORPORATION
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3476614
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3444671
CY2023Q1 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-23423
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VA
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
54-1680165
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3600 La Grange Parkway
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Toano
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23168
CY2023Q1 dei City Area Code
CityAreaCode
804
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
843-2360
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $1.00 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
CFFI
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
718000
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1595200000
CY2023Q1 cffi Restricted Stocks
RestrictedStocks
5831000
CY2022Q4 cffi Restricted Stocks
RestrictedStocks
1120000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43509000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43849000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
8856000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
8982000
CY2023Q1 us-gaap Goodwill
Goodwill
25191000
CY2022Q4 us-gaap Goodwill
Goodwill
25191000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1611000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1679000
CY2023Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
21015000
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
20909000
CY2023Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1025000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
21018000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
22014000
CY2022Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
366000
CY2023Q1 us-gaap Other Assets
OtherAssets
56766000
CY2022Q4 us-gaap Other Assets
OtherAssets
59862000
CY2023Q1 us-gaap Assets
Assets
2440333000
CY2022Q4 us-gaap Assets
Assets
2332317000
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
596160000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
605210000
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
904228000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1017356000
CY2023Q1 us-gaap Time Deposits
TimeDeposits
495410000
CY2022Q4 us-gaap Time Deposits
TimeDeposits
381294000
CY2023Q1 us-gaap Interest Expense Trust Preferred Securities
InterestExpenseTrustPreferredSecurities
293000
CY2023Q1 us-gaap Deposits
Deposits
1995798000
CY2022Q4 us-gaap Deposits
Deposits
2003860000
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3434528
CY2023Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
15596000
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
19610000
CY2023Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
68624000
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
7051000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84220000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26661000
CY2023Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
551477000
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
557128000
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
513625000
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
512591000
CY2023Q1 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
26330000
CY2022Q1 us-gaap Interest Expense Trust Preferred Securities
InterestExpenseTrustPreferredSecurities
284000
CY2022Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
14259000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
40834000
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
145579000
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
36592000
CY2023Q1 us-gaap Interest Expense
InterestExpense
4347000
CY2022Q1 us-gaap Interest Expense
InterestExpense
1755000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
24958000
CY2023Q1 cffi Long Term Borrowings
LongTermBorrowings
30049000
CY2022Q4 cffi Long Term Borrowings
LongTermBorrowings
30106000
CY2023Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
25395000
CY2022Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
25386000
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1612000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
950000
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
38716000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
39190000
CY2023Q1 us-gaap Liabilities
Liabilities
2237149000
CY2022Q4 us-gaap Liabilities
Liabilities
2136084000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3444671
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3476614
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
135754
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
145677
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
3309000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3331000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10135000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12047000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
221062000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
217214000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31923000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-36958000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
202583000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
195634000
CY2023Q1 us-gaap Minority Interest
MinorityInterest
601000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
599000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
203184000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
196233000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2440333000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2332317000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
26060000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
20484000
CY2023Q1 cffi Interest Income Money Market Deposits And Federal Funds Sold
InterestIncomeMoneyMarketDepositsAndFederalFundsSold
176000
CY2022Q1 cffi Interest Income Money Market Deposits And Federal Funds Sold
InterestIncomeMoneyMarketDepositsAndFederalFundsSold
106000
CY2023Q1 us-gaap Interest Income Securities Us Treasury And Other Us Government
InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment
1035000
CY2022Q1 us-gaap Interest Income Securities Us Treasury And Other Us Government
InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment
293000
CY2023Q1 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
947000
CY2022Q1 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
668000
CY2023Q1 cffi Interest Income State And Municipal Obligations Operating Tax Exempt
InterestIncomeStateAndMunicipalObligationsOperatingTaxExempt
618000
CY2022Q1 cffi Interest Income State And Municipal Obligations Operating Tax Exempt
InterestIncomeStateAndMunicipalObligationsOperatingTaxExempt
350000
CY2023Q1 cffi Interest Income State And Municipal Obligations Operating Taxable
InterestIncomeStateAndMunicipalObligationsOperatingTaxable
184000
CY2022Q1 cffi Interest Income State And Municipal Obligations Operating Taxable
InterestIncomeStateAndMunicipalObligationsOperatingTaxable
113000
CY2023Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
285000
CY2022Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
217000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20476000
CY2023Q1 cffi Provision For Credit Losses
ProvisionForCreditLosses
2050000
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
29305000
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
22231000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-14690000
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-17000
CY2022Q1 cffi Provision For Credit Losses
ProvisionForCreditLosses
-328000
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
22908000
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
20804000
CY2023Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1794000
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
2695000
CY2023Q1 cffi Noninterest Income Interchange Income
NoninterestIncomeInterchangeIncome
1520000
CY2022Q1 cffi Noninterest Income Interchange Income
NoninterestIncomeInterchangeIncome
1430000
CY2023Q1 cffi Noninterest Income Service Charges On Deposit Accounts
NoninterestIncomeServiceChargesOnDepositAccounts
1048000
CY2022Q1 cffi Noninterest Income Service Charges On Deposit Accounts
NoninterestIncomeServiceChargesOnDepositAccounts
1046000
CY2023Q1 cffi Non Interest Investment Income In Other Equity Interests
NonInterestInvestmentIncomeInOtherEquityInterests
113000
CY2022Q1 cffi Non Interest Investment Income In Other Equity Interests
NonInterestInvestmentIncomeInOtherEquityInterests
138000
CY2023Q1 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
494000
CY2022Q1 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
853000
CY2023Q1 cffi Noninterest Income Wealth Management Services Income Net
NoninterestIncomeWealthManagementServicesIncomeNet
614000
CY2022Q1 cffi Noninterest Income Wealth Management Services Income Net
NoninterestIncomeWealthManagementServicesIncomeNet
647000
CY2023Q1 cffi Noninterest Income Mortgage Lender Services Income
NoninterestIncomeMortgageLenderServicesIncome
451000
CY2022Q1 cffi Noninterest Income Mortgage Lender Services Income
NoninterestIncomeMortgageLenderServicesIncome
424000
CY2023Q1 cffi Noninterest Income Other Service Charges And Fees
NoninterestIncomeOtherServiceChargesAndFees
391000
CY2022Q1 cffi Noninterest Income Other Service Charges And Fees
NoninterestIncomeOtherServiceChargesAndFees
374000
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-5000
CY2023Q1 cffi Other Noninterest Income Loss Net
OtherNoninterestIncomeLossNet
1023000
CY2022Q1 cffi Other Noninterest Income Loss Net
OtherNoninterestIncomeLossNet
-878000
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
7443000
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
6729000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
13898000
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
11856000
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
2044000
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
2209000
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
6459000
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
6146000
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
22401000
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
20211000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7950000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7322000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1453000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1587000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
6497000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
5735000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
56000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
106000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
6441000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5629000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.86
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.86
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.59
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.59
CY2023Q1 us-gaap Profit Loss
ProfitLoss
6497000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
5735000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5281000
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
7000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-263000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
920000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5035000
CY2023Q1 cffi Gains Losses On Sales Of Loans Held For Sale
GainsLossesOnSalesOfLoansHeldForSale
1794000
CY2022Q1 cffi Gains Losses On Sales Of Loans Held For Sale
GainsLossesOnSalesOfLoansHeldForSale
2695000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-328000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13777000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
11532000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8042000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
56000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
106000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11476000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8148000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
196233000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
6497000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5035000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
474000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47000
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2455000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1521000
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
54000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
203184000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
211024000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
5735000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13777000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
511000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
46000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
723000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1420000
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
118000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
201278000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
6497000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
5735000
CY2023Q1 cffi Provision For Credit Losses
ProvisionForCreditLosses
2050000
CY2022Q1 cffi Provision For Credit Losses
ProvisionForCreditLosses
-328000
CY2023Q1 cffi Fair Value Adjustment Accretion Of Acquisition Related Fair Value Adjustments
FairValueAdjustmentAccretionOfAcquisitionRelatedFairValueAdjustments
228000
CY2022Q1 cffi Fair Value Adjustment Accretion Of Acquisition Related Fair Value Adjustments
FairValueAdjustmentAccretionOfAcquisitionRelatedFairValueAdjustments
362000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
474000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
511000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
988000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1135000
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-281000
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-811000
CY2022Q1 cffi Provision For Indemnifications
ProvisionForIndemnifications
-583000
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
83000
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
77000
CY2023Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
236000
CY2022Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
177000
CY2023Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
105023000
CY2022Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
227612000
CY2023Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
115734000
CY2022Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
189976000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
102000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-126000
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
143000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2317000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1052000
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
662000
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-281000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-978000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1289000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
165000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
41197000
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
19729000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
14629000
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
14364000
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
76494000
CY2023Q1 cffi Maturities Purchases Of Time Deposits Net
MaturitiesPurchasesOfTimeDepositsNet
-744000
CY2022Q1 cffi Maturities Purchases Of Time Deposits Net
MaturitiesPurchasesOfTimeDepositsNet
-247000
CY2023Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
39057000
CY2022Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
44274000
CY2023Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
41904000
CY2022Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
72818000
CY2023Q1 cffi Net Decrease Increase In Community Banking Loans Held For Investment
NetDecreaseIncreaseInCommunityBankingLoansHeldForInvestment
36068000
CY2022Q1 cffi Net Decrease Increase In Community Banking Loans Held For Investment
NetDecreaseIncreaseInCommunityBankingLoansHeldForInvestment
2320000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
515000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1203000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
29000
CY2022Q1 cffi Increase Decrease In Collateral Posted With Other Financial Institutions Net
IncreaseDecreaseInCollateralPostedWithOtherFinancialInstitutionsNet
-3880000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4714000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
186000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39494000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-90485000
CY2023Q1 cffi Increase Decrease In Deposits Excluding Time Deposits
IncreaseDecreaseInDepositsExcludingTimeDeposits
-122178000
CY2022Q1 cffi Increase Decrease In Deposits Excluding Time Deposits
IncreaseDecreaseInDepositsExcludingTimeDeposits
79999000
CY2023Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
114116000
CY2022Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-24952000
CY2023Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
108987000
CY2022Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-2301000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2455000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
723000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
1521000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
1420000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-61000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-122000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
96888000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50481000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
57559000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1193000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26661000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
267745000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84220000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268938000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
3683000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
2047000
CY2023Q1 cffi Noncash Investing And Financing Activities Adoption Of New Accounting Standard
NoncashInvestingAndFinancingActivitiesAdoptionOfNewAccountingStandard
1072000
CY2022Q1 cffi Liabilities Assumed To Acquire Right Of Use Assets Under Operating Leases
LiabilitiesAssumedToAcquireRightOfUseAssetsUnderOperatingLeases
838000
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Nature of Operations:</b> The Corporation is a bank holding company incorporated under the laws of the Commonwealth of Virginia. The Corporation owns all of the stock of its subsidiary, C&amp;F Bank, which is an independent commercial bank chartered under the laws of the Commonwealth of Virginia. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 7.5pt 0pt 7.5pt;"><span style="margin-left:0pt;margin-right:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">C&amp;F Bank has five wholly-owned subsidiaries: C&amp;F Mortgage Corporation (C&amp;F Mortgage), C&amp;F Finance Company (C&amp;F Finance), C&amp;F Wealth Management Corporation (C&amp;F Wealth Management), C&amp;F Insurance Services, Inc. (C&amp;F Insurance) and CVB Title Services, Inc. (CVB Title), all incorporated under the laws of the Commonwealth of Virginia. C&amp;F Mortgage, organized in September 1995, originates and sells residential mortgages, provides mortgage loan origination services to third-party lenders and, through its subsidiary Certified Appraisals LLC, provides ancillary mortgage loan production services for residential appraisals. C&amp;F Mortgage owns a 51 percent interest in C&amp;F Select LLC, which was organized in January 2019 and is also engaged in the business of originating and selling residential mortgages. C&amp;F Finance, acquired in September 2002, is a finance company purchasing automobile, marine and recreational vehicle (RV) loans through indirect lending programs. C&amp;F Wealth Management, organized in April 1995, is a full-service brokerage firm offering a comprehensive range of wealth management services and insurance products through third-party service providers. C&amp;F Insurance and CVB Title were organized for the primary purpose of owning equity interests in an independent insurance agency and a full service title and settlement agency, respectively. Business segment data is presented in Note 11.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p>
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Reclassification:</b> Certain reclassifications have been made to the prior period financial statements to conform to the current period presentation.  None of these reclassifications are considered material and did not affect net income or total equity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p>
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
1635718000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
40518000
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1595200000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
22014000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
196233000
CY2023Q1 us-gaap Financing Receivable Transfer To Held For Investment Allowance For Credit Loss Expense
FinancingReceivableTransferToHeldForInvestmentAllowanceForCreditLossExpense
0
CY2023Q1 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
0
CY2023Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
551477000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
891000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
38743000
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
513625000
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
557128000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
365000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
44902000
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
512591000
CY2023Q1 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
2600000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
98510000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
97294000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
212795000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
200849000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
216905000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
195248000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
23267000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
20234000
CY2023Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
551477000
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
513625000
CY2022Q1 cffi Available For Sale Securities Sold Number
AvailableForSaleSecuritiesSoldNumber
0
CY2023Q1 cffi Available For Sale Securities Sold Number
AvailableForSaleSecuritiesSoldNumber
0
CY2023Q1 cffi Available For Sale Securities Gross Realized Losses From Maturities And Calls
AvailableForSaleSecuritiesGrossRealizedLossesFromMaturitiesAndCalls
5000
CY2023Q1 cffi Available For Sale Securities Gross Realized Gains Losses Net From Maturities And Calls
AvailableForSaleSecuritiesGrossRealizedGainsLossesNetFromMaturitiesAndCalls
-5000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
19730000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
14629000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
138296000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2764000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
329993000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
35979000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
468289000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
38743000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
538
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
468290000
CY2023Q1 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
271692000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
12523000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
209967000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
32379000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
481659000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
44902000
CY2023Q1 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
5830000
CY2022Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
1120000
CY2023Q1 cffi Restricted Stocks Other Than Temporary Impairment
RestrictedStocksOtherThanTemporaryImpairment
0
CY2023Q1 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
6300000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
1673195000
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
1635718000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
40834000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
40518000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1632361000
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1595200000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
1673195000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest90 Days Or More Past Due Still Accruing
FinancingReceivableExcludingAccruedInterest90DaysOrMorePastDueStillAccruing
565000
CY2023Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
19000
CY2023Q1 cffi Financing Receivable Reversal Of Interest Income Upon Placing Loans On Nonaccrual Status
FinancingReceivableReversalOfInterestIncomeUponPlacingLoansOnNonaccrualStatus
0
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
909000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
1189000
CY2023Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
47000
CY2022Q4 cffi Financing Receivables Modified Loans Weighted Average Interest Rate
FinancingReceivablesModifiedLoansWeightedAverageInterestRate
0.0875
CY2023Q1 cffi Financing Receivables Modified Loans Weighted Average Interest Rate
FinancingReceivablesModifiedLoansWeightedAverageInterestRate
0.080
CY2023Q1 cffi Financing Receivables Modified Loans Weighted Average Extension Term
FinancingReceivablesModifiedLoansWeightedAverageExtensionTerm
P4Y10M24D
CY2023Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2022Q4 cffi Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Outstanding Principal Balance
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesOutstandingPrincipalBalance
42679000
CY2022Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Carrying Amount Net
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesCarryingAmountNet
38867000
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1635718000
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
191000
CY2022Q4 cffi Financing Receivable Recorded Investment Current And1 To29 Days Past Due Nonaccrual Status
FinancingReceivableRecordedInvestmentCurrentAnd1To29DaysPastDueNonaccrualStatus
244000000000
CY2022Q4 cffi Financing Receivable Recorded Investment Equal To Greater Than90 Days Past Due Nonaccrual Status
FinancingReceivableRecordedInvestmentEqualToGreaterThan90DaysPastDueNonaccrualStatus
945000
CY2022Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2022Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0
CY2022Q4 cffi Financing Receivables Impaired Troubled Debt Restructuring Amount
FinancingReceivablesImpairedTroubledDebtRestructuringAmount
823000
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
823000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
62000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
761000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
51000
CY2022 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
834000
CY2022 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
37000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
40518000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
1950000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
3213000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
1088000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
40834000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
1950000
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
-328000
CY2023Q1 cffi Provision For Unfunded Commitments
ProvisionForUnfundedCommitments
100000
CY2023Q1 cffi Provision For Credit Losses
ProvisionForCreditLosses
2050000
CY2022Q1 cffi Provision For Credit Losses
ProvisionForCreditLosses
-328000
CY2023Q1 cffi Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff
81000
CY2023Q1 cffi Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
1446000
CY2023Q1 cffi Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff
938000
CY2023Q1 cffi Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff
320000
CY2023Q1 cffi Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff
135000
CY2023Q1 cffi Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff
285000
CY2023Q1 cffi Financing Receivable Excluding Accrued Interest Revolving Writeoff
FinancingReceivableExcludingAccruedInterestRevolvingWriteoff
8000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
3213000
CY2023Q1 cffi Financing Receivable Collateral Dependent Loans Which Required Sale Of Collateral And Borrower Had Financial Difficulty
FinancingReceivableCollateralDependentLoansWhichRequiredSaleOfCollateralAndBorrowerHadFinancialDifficulty
0
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
40157000
CY2022Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-328000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1372000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1311000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
39768000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
51000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
40467000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
40518000
CY2022Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
823000
CY2022Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1633440000
CY2022Q4 cffi Financing Receivable Acquired Loans
FinancingReceivableAcquiredLoans
1455000
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1635718000
CY2022Q4 cffi Loans And Leases Receivable Gross Excluding Consumer Finance Loans
LoansAndLeasesReceivableGrossExcludingConsumerFinanceLoans
1161161000
CY2023Q1 us-gaap Goodwill
Goodwill
25190000
CY2022Q4 us-gaap Goodwill
Goodwill
25190000
CY2022Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2023Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1610000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1680000
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
11000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3116000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1505000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3116000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1437000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
68000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
75000
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
9717
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
493000
CY2023Q1 cffi Stock Repurchase Program Number Of Shares Withheld
StockRepurchaseProgramNumberOfSharesWithheld
6257
CY2022Q1 cffi Stock Repurchase Program Number Of Shares Withheld
StockRepurchaseProgramNumberOfSharesWithheld
4434
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
6441000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5629000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3464895
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3464895
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3547780
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3547780
CY2023Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
2240000
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
2160000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-115000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
24000
CY2023Q1 us-gaap Other Income
OtherIncome
3430000
CY2022 cffi Other Income Net Of Tax
OtherIncomeNetOfTax
3650000
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
29305000
CY2023Q1 us-gaap Interest Expense
InterestExpense
4347000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
24958000
CY2023Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1794000
CY2023Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
5649000
CY2023Q1 us-gaap Revenues
Revenues
32401000
CY2023Q1 cffi Provision For Credit Losses
ProvisionForCreditLosses
2050000
CY2023Q1 cffi Noninterest Expense Net
NoninterestExpenseNet
22401000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7950000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1453000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
6497000
CY2023Q1 us-gaap Additions To Other Assets Amount
AdditionsToOtherAssetsAmount
515000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
988000
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
22231000
CY2022Q1 us-gaap Interest Expense
InterestExpense
1755000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20476000
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
2695000
CY2022Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
4034000
CY2022Q1 us-gaap Revenues
Revenues
27205000
CY2022Q1 cffi Provision For Credit Losses
ProvisionForCreditLosses
-328000
CY2022Q1 cffi Noninterest Expense Net
NoninterestExpenseNet
20211000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7322000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1587000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
5735000
CY2022Q1 us-gaap Additions To Other Assets Amount
AdditionsToOtherAssetsAmount
1156000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1135000
CY2023Q1 us-gaap Assets
Assets
2440333000
CY2022Q4 us-gaap Assets
Assets
2332317000
CY2023Q1 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
0
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2682000
CY2022Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2601000
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
595000
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
752000
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
401000
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
468000
CY2023Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
396000
CY2022Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
229000
CY2023Q1 us-gaap Loan Processing Fee
LoanProcessingFee
258000
CY2022Q1 us-gaap Loan Processing Fee
LoanProcessingFee
502000
CY2023Q1 cffi Travel Entertainment And Employee Education Expense
TravelEntertainmentAndEmployeeEducationExpense
348000
CY2022Q1 cffi Travel Entertainment And Employee Education Expense
TravelEntertainmentAndEmployeeEducationExpense
442000
CY2023Q1 us-gaap Communication
Communication
275000
CY2022Q1 us-gaap Communication
Communication
367000
CY2022Q1 cffi Provision For Loss On Indemnification
ProvisionForLossOnIndemnification
-583000
CY2023Q1 cffi All Other Noninterest Expenses
AllOtherNoninterestExpenses
1504000
CY2022Q1 cffi All Other Noninterest Expenses
AllOtherNoninterestExpenses
1368000
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
6459000
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
6146000

Files In Submission

Name View Source Status
cffi-20230331_def.xml Edgar Link unprocessable
0000913341-23-000027-index-headers.html Edgar Link pending
0000913341-23-000027-index.html Edgar Link pending
0000913341-23-000027.txt Edgar Link pending
0000913341-23-000027-xbrl.zip Edgar Link pending
cffi-20230331.xsd Edgar Link pending
cffi-20230331x10q.htm Edgar Link pending
cffi-20230331xex31d1.htm Edgar Link pending
cffi-20230331xex31d2.htm Edgar Link pending
cffi-20230331xex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
cffi-20230331_lab.xml Edgar Link unprocessable
cffi-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cffi-20230331x10q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cffi-20230331_cal.xml Edgar Link unprocessable